UNITAID: 2013 Tuberculosis Diagnostic Technology and Market Landscape - semi-annual update
The purpose of the report is to highlight developments that have occurred since July 2013 – namely, in the areas of policy development, implementation and scale-up of the Xpert® MTB/RIF assay and efforts to define the characteristics of next-generation molecular tests that could replace smear microscopy.
The UNITAID Tuberculosis Diagnostic Technology and Market Landscape is published annually and is prepared as part of a broad and ongoing effort to understand the technology and market landscape for tuberculosis (TB) diagnostics. The first edition of the landscape report was published in July 2012, with a semi-annual update published in December 2012. A second edition was published in July 2013. These documents are available at http://www.unitaid.eu/en/resources/publications/technical-reports.
This current document is a semi-annual update to the second edition report. The purpose of this document is to highlight developments that have occurred since July 2013 – namely, in the areas of policy development, implementation and scale-up of the Xpert® MTB/RIF assay and efforts to define the characteristics of next-generation molecular tests that could replace smear microscopy. An updated technology pipeline is included for reference; however, a detailed report on newer technologies, including technologies other than nucleic acid amplification tests (NAATs), will be published in 2014 (third edition).
